1-Acetyl-piperidine-4-carboxylic acid Methyl ester
|
- $298 - $1048
- Product name: 1-Acetyl-piperidine-4-carboxylic acid Methyl ester
- CAS: 126291-66-5
- MF: C9H15NO3
- MW: 185.22
- EINECS:
- MDL Number:MFCD02862113
- Synonyms:1-Acetyl-piperidine-4-carboxylic acid Methyl ester;4-Piperidinecarboxylic acid, 1-acetyl-, Methyl ester;methyl 1-acetylpiperidine-4-carboxylate;1-Acetyl-4-piperidinecarboxylic acid methyl ester
4 prices
Selected condition:
Brand
- Absolute Chiral
- American Custom Chemicals Corporation
- Crysdot
Package
- 5MG
- 500mg
- 1g
- 5g
- ManufacturerAbsolute Chiral
- Product numberO1625-00-N
- Product descriptionmethyl1-acetylpiperidine-4-carboxylate 90%
- Packaging500mg
- Price$298
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0294986
- Product descriptionMETHYL-1-ACETYLPIPERIDINE-4-CARBOXYLATE 95.00%
- Packaging5MG
- Price$495.2
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11304507
- Product description1-Acetyl-piperidine-4-carboxylicacidmethylester 95+%
- Packaging1g
- Price$355
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11304507
- Product description1-Acetyl-piperidine-4-carboxylicacidmethylester 95+%
- Packaging5g
- Price$1048
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Absolute Chiral | O1625-00-N | methyl1-acetylpiperidine-4-carboxylate 90% | 500mg | $298 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CHM0294986 | METHYL-1-ACETYLPIPERIDINE-4-CARBOXYLATE 95.00% | 5MG | $495.2 | 2021-12-16 | Buy |
| Crysdot | CD11304507 | 1-Acetyl-piperidine-4-carboxylicacidmethylester 95+% | 1g | $355 | 2021-12-16 | Buy |
| Crysdot | CD11304507 | 1-Acetyl-piperidine-4-carboxylicacidmethylester 95+% | 5g | $1048 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




